agreed, An unimaginally massive market. And just as big is the non Alzheimer's OFF LABEL market for the entire family of CNS diseases, which are vast. The designated RARE CNS disease category (not talking the major ones like Parkinsons or Austism, which are massive. And what about clinical depression? HUGE markets)...but like I was saying the category of designated RARE CNS diseases has about 200 listed!...)
They won't be able to keep SAVA's drug in stock!
A combined market easily as big as the 200 or so cancer drugs, which are a 150 billion dollar a year extravaganza.
"Everybody's doin it."
Market Data 
Markets 
AI
